Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2010
07/29/2010WO2010085589A2 Desensitizing drug product
07/29/2010WO2010085347A1 Peg-lipid conjugates for icreasing the solubility of drug compounds
07/29/2010WO2010085259A1 Viral detection liposomes and method
07/29/2010WO2010085195A2 A new coating composition and use thereof
07/29/2010WO2010085027A1 Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
07/29/2010WO2010084637A1 Tablet for oral administration having excellent disintegrability and dissolvability
07/29/2010WO2010084601A1 Powdery fat-containing soft capsules to be masticated
07/29/2010WO2010084458A1 A novel dermaceutical cream made using sodium fusidate, antifungals and steroids
07/29/2010WO2010084457A1 A novel dermaceutical cream made using sodium fusidate and steroids
07/29/2010WO2010084397A2 Modified release solid pharmaceutical compositions of trimetazidine and process thereof
07/29/2010WO2010084298A1 Stable vaccine compositions and methods of use
07/29/2010WO2010084199A1 Drug delivery system for use in the treatment of vascular and vessel-related pathologies
07/29/2010WO2010084129A1 Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids
07/29/2010WO2010084111A2 Pharmaceutical composition of ibandronate sodium salt or a hydrate thereof
07/29/2010WO2010084088A2 Starch nanoparticles for drug delivery systems
07/29/2010WO2010084066A1 Pharmaceutical composition comprising aleglitazar
07/29/2010WO2010084060A1 Starch copolymers and nanoparticles thereof for drug delivery systems
07/29/2010WO2010084041A2 Pharmaceutical compositions with superior product performance and patient compliance
07/29/2010WO2010084038A1 Controlled release pharmaceutical or food formulation and process for its preparation
07/29/2010WO2010083894A1 Abuse resistant melt extruded formulation having reduced alcohol interaction
07/29/2010WO2010083843A1 Controlled release formulations with continuous efficacy
07/29/2010WO2010083778A1 Lung targeting injectable pharmaceutical composition of liposome
07/29/2010WO2010083636A1 An eyedrops of the deproteinized calf blood extract
07/29/2010WO2010083615A1 Compositions and methods for silencing apolipoprotein c-iii expression
07/29/2010WO2010064958A3 Protein kinase c inhibitors exhibiting an anti-inflammatory, anti-allergic and anti-asthma effect
07/29/2010WO2010056039A3 Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability
07/29/2010WO2010047559A3 Sustained-release pharmaceutical formulations
07/29/2010WO2010044597A3 Drug delivery device
07/29/2010WO2010043717A3 Pharmaceutical topical compositions
07/29/2010WO2010039641A3 Long term drug delivery devices with polyurethane-based polymers and their manufacture
07/29/2010WO2010025577A3 Preparation for preventing and/or treating and/or avoiding the spreading of respiratory tract diseases
07/29/2010WO2010023689A3 Microparticles
07/29/2010WO2010006697A3 Powders for reconstitution
07/29/2010WO2010003647A3 Artificial oxygen carriers and use thereof
07/29/2010WO2009089632A8 Implantable devices for promoting reendothelialization and methods of use thereof
07/29/2010WO2009076158A8 Compositions for inducing immune responses
07/29/2010US20100190760 Process for Making Crystals
07/29/2010US20100189815 Colon cleansing compositions and methods
07/29/2010US20100189801 Drug Delivery Systems and Use Thereof
07/29/2010US20100189800 Continous double emulsion process for making microparticles
07/29/2010US20100189799 Granule coated with urethane resin
07/29/2010US20100189798 Control of erwinia amylovora with vinylglycines and bacteria that produce vinylglycines
07/29/2010US20100189797 Oral antidepressant formulation
07/29/2010US20100189796 Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
07/29/2010US20100189795 Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
07/29/2010US20100189794 Nucleic acid hydrogel via rolling circle amplification
07/29/2010US20100189793 Electrophoretic transdermal delivery system
07/29/2010US20100189792 In vivo gene transfer methods for wound healing
07/29/2010US20100189791 Delayed release rasagiline malate formulation
07/29/2010US20100189790 Delayed release rasagiline formulation
07/29/2010US20100189789 Micronized Tanaproget, Compositions, and Methods of Preparing the Same
07/29/2010US20100189788 Delayed release rasagiline base formulation
07/29/2010US20100189787 Delayed release rasagiline citrate formulation
07/29/2010US20100189786 Crystalline tolterodine tartarate and a pharmaceutical composition containing the same
07/29/2010US20100189785 Use of D-ribose for fatigued subjects
07/29/2010US20100189784 Use of Alkylphophocholine in Combination with Antitumor Medication for the Treatment of Benign and Malignant Oncoses in Humans and Mammals
07/29/2010US20100189783 Relating to anti-hiv tablet formulations
07/29/2010US20100189782 Compositions Comprising Carisoprodol and Methods of Use Thereof
07/29/2010US20100189781 Alkoxyalkyl s-prenylthiosalicylates for treatment of cancer
07/29/2010US20100189780 Novel Powderous Medicaments Comprising Tiotropium and Salmeterol and Lactose as Carrier
07/29/2010US20100189779 In vivo device, system and usage thereof
07/29/2010US20100189778 Opioid delivery system
07/29/2010US20100189777 Functionalized nanocompartments with a transport system
07/29/2010US20100189776 Anti-androgen peptides and uses thereof in cancer therapy
07/29/2010US20100189775 Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma
07/29/2010US20100189774 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system
07/29/2010US20100189773 5-cyano-4- (pyrrolo [2,3] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/29/2010US20100189772 Compositions of TLR ligands and antivirals
07/29/2010US20100189771 Fixed ratio drug combination treatments for solid tumors
07/29/2010US20100189769 Polypeptide Films and Methods
07/29/2010US20100189768 Compressed chewing gum tablet comprising taste-masking agent
07/29/2010US20100189767 Probiotic compositions and methods of making same
07/29/2010US20100189763 Controlled release systems from polymer blends
07/29/2010US20100189762 Triarylmethane analogs and their use in treating cancers
07/29/2010US20100189761 Methods for Prevention and/or Treatment of Capsular Contracture
07/29/2010US20100189760 Synthetic Cell Platforms and Methods of Use Thereof
07/29/2010US20100189757 Drug depot implant designs and methods of implantation
07/29/2010US20100189755 Dryer Sheets and a Method for Treating Skin
07/29/2010US20100189752 Pelleted mineral supplement for land animals
07/29/2010US20100189751 Percutaneous absorption type patch
07/29/2010US20100189680 Methods of Treating Various Cancers Using Melanoma Differentiating Associated Protein-7
07/29/2010US20100189667 Vesicles of high molecular weight silicone polyethers
07/29/2010US20100189662 DMS (derma membrane structure) in Foam Creams
07/29/2010US20100189661 Polymer-bound uv absorbers in personal care compositions
07/29/2010US20100189650 Near-Infrared Responsive Carbon Nanostructures
07/29/2010US20100189596 Composite emulsifier, an emulsion prepared from it and the preparation method thereof
07/29/2010DE102009006228A1 Liposomal composition, useful to treat e.g. brain metastases, comprises liposomal vesicle, where the vesicles consist of a base lipid, a membrane stabilizer, a helper lipid and a charge carrier, and contain a cytostatic agent and a ligand
07/29/2010CA2750711A1 Processes for coating a carrier with microparticles
07/29/2010CA2750561A1 Compositions and methods for silencing apolipoprotein c-iii expression
07/29/2010CA2750400A1 Controlled release formulations with continuous efficacy
07/29/2010CA2750381A1 Sustained released delivery of one or more agents
07/29/2010CA2750321A1 Stable vaccine compositions and methods of use
07/29/2010CA2750003A1 Controlled release systems from polymer blends
07/29/2010CA2749993A1 Continuous double emulsion process for making microparticles
07/29/2010CA2749955A1 Solid pharmaceutical composition comprising amlodipine and losartan with improved stability
07/29/2010CA2748896A1 Pharmaceutical composition comprising aleglitazar
07/29/2010CA2748895A1 Pharmaceutical compositions with superior product performance and patient compliance
07/29/2010CA2748464A1 Abuse resistant melt extruded formulation having reduced alcohol interaction
07/29/2010CA2745737A1 Controlled release pharmaceutical or food formulation and process for its preparation
07/28/2010EP2210956A2 Method to inhibit cell growth using oligonucleotides
1 ... 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 ... 2991